Docking Study for Assessment of Anti-Cancer Potential of Carica Papaya Extract and in-vitro Evaluation of Anti-Cancer Activities

Abstract

Carica papaya fruit extracts are subjected to phytochemical screening, molecular docking, and in vitro cytotoxicity testing in this investigation to determine their potential anticancer properties. Utilizing phytochemical profiling, the following compounds were discovered: alkaloids, tannins, flavonoids, terpenoids, phenols, and glycosides. According to the findings of Insilco molecular docking experiments, 1,11-dodecadiene is a potential ligand that possesses significant binding affinities to cancer-associated proteins such as EGFR (-5.3 kcal/mol), KRAS (-5.1), and MET (-4.8). ALK (-4.7 kcal/mol) and BRAF (-6.2) were also involved in the interaction between Silan amine n-phenyl and BRAF. The MTT assay demonstrated that the ethanolic extract exhibited a noteworthy cytotoxic effect on A549 lung cancer cells, as evidenced by an IC50 value of 120.85 µg/ml following a treatment period of 48 hours. Given these findings, it is reasonable to assume that the ethanolic extract of Carica papaya may possess anticancer effects. Therefore, it is necessary to conduct in vivo research and extract the active ingredient for medicinal purposes.